Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.
…
continue reading
Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.
…
continue reading
Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.
…
continue reading
Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.
…
continue reading
Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.
…
continue reading
Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.
…
continue reading
Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.
…
continue reading
Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.
…
continue reading
Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.
…
continue reading
Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.
…
continue reading
Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.
…
continue reading
Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.
…
continue reading
Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.
…
continue reading
Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.
…
continue reading
Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.
…
continue reading
Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.
…
continue reading
Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.
…
continue reading
Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.
…
continue reading
Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.
…
continue reading
Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.
…
continue reading
Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.
…
continue reading
1
Should Small Cell Lung Cancer Patients Who Respond to Chemo Receive Consolidation Radiotherapy?
4:36
4:36
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích
4:36
Dr. Nasser Hanna outlines the possible benefits of consolidation chest radiation for small cell lung cancer patients who respond well to chemotherapy.Bởi cancerGRACE - H. Jack West, MD
…
continue reading
1
Should Small Cell Lung Cancer Patients Who Respond to Chemo Receive Consolidation Radiotherapy?
4:36
4:36
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích
4:36
Dr. Nasser Hanna outlines the possible benefits of consolidation chest radiation for small cell lung cancer patients who respond well to chemotherapy.Bởi cancerGRACE - H. Jack West, MD
…
continue reading
What puts you at risk for inherited kidney cancer? Dr. Nizar Tannir discusses the signs doctors look for to determine if a kidney cancer patient should be screened for a familial syndrome.Bởi cancerGRACE - H. Jack West, MD
…
continue reading
What puts you at risk for inherited kidney cancer? Dr. Nizar Tannir discusses the signs doctors look for to determine if a kidney cancer patient should be screened for a familial syndrome.Bởi cancerGRACE - H. Jack West, MD
…
continue reading
1
Should All Small Cell Lung Cancer Patients Receive Prophylactic Cranial Irradiation?
5:28
5:28
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích
5:28
The doctors discuss the circumstances under which small cell lung cancer patients should receive prophylactic cranial irradiation.Bởi cancerGRACE - H. Jack West, MD
…
continue reading
1
Should All Small Cell Lung Cancer Patients Receive Prophylactic Cranial Irradiation?
5:28
5:28
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích
5:28
The doctors discuss the circumstances under which small cell lung cancer patients should receive prophylactic cranial irradiation.Bởi cancerGRACE - H. Jack West, MD
…
continue reading
NanoString Technology may help doctors learn what is driving tumor growth in kidney cancer patients and, therefore, determine what treatments may be most effective for them.Bởi cancerGRACE - H. Jack West, MD
…
continue reading
NanoString Technology may help doctors learn what is driving tumor growth in kidney cancer patients and, therefore, determine what treatments may be most effective for them.Bởi cancerGRACE - H. Jack West, MD
…
continue reading
1
Is Necitumumab An Effective Antibody Against EGFR for Patients with Squamous Lung Cancer?
2:27
2:27
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích
2:27
Dr. Nasser Hanna discusses the SQUIRE trial of the EGFR antibody Necitumumab in patients with squamous lung cancer. Though it achieved a statistical increase in OS, he does not consider it clinically relevant.Bởi cancerGRACE - H. Jack West, MD
…
continue reading
1
Is Necitumumab An Effective Antibody Against EGFR for Patients with Squamous Lung Cancer?
2:27
2:27
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích
2:27
Dr. Nasser Hanna discusses the SQUIRE trial of the EGFR antibody Necitumumab in patients with squamous lung cancer. Though it achieved a statistical increase in OS, he does not consider it clinically relevant.Bởi cancerGRACE - H. Jack West, MD
…
continue reading
1
How is the Heng Criteria Applied to Kidney Cancer Patients?
4:40
4:40
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích
4:40
Dr. Daniel Heng is the namesake of the Heng Criteria, which evaluates various factors of kidney cancer patients to determine their prognoses.Bởi cancerGRACE - H. Jack West, MD
…
continue reading
1
How is the Heng Criteria Applied to Kidney Cancer Patients?
4:40
4:40
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích
4:40
Dr. Daniel Heng is the namesake of the Heng Criteria, which evaluates various factors of kidney cancer patients to determine their prognoses.Bởi cancerGRACE - H. Jack West, MD
…
continue reading
1
Angiogenesis, the Sequel: Does Cyramza (Ramucirumab) Make a Difference for Second Line Treatment?
7:28
7:28
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích
7:28
The REVEL trial studied 1,200 non-small cell lung cancer patients to see if the drug Cyramza (ramucirumab) improved overall surival. The doctors had mixed feelings about the results.Bởi cancerGRACE - H. Jack West, MD
…
continue reading
1
Angiogenesis, the Sequel: Does Cyramza (Ramucirumab) Make a Difference for Second Line Treatment?
7:28
7:28
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích
7:28
The REVEL trial studied 1,200 non-small cell lung cancer patients to see if the drug Cyramza (ramucirumab) improved overall surival. The doctors had mixed feelings about the results.Bởi cancerGRACE - H. Jack West, MD
…
continue reading
Dr. Lauren Harshman explains what PD1 (an immune T-cell) and PDL1 (a protein on the PD1 T-cell) are and how new drugs impact them to fight kidney cancer.Bởi cancerGRACE - H. Jack West, MD
…
continue reading
Dr. Lauren Harshman explains what PD1 (an immune T-cell) and PDL1 (a protein on the PD1 T-cell) are and how new drugs impact them to fight kidney cancer.Bởi cancerGRACE - H. Jack West, MD
…
continue reading
1
Zykadia for ALK Positive Lung Cancer: New Drug, New Hope
7:22
7:22
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích
7:22
The doctors discuss the new FDA-approved drug for ALK positive lung cancer patients, Zykadia (ceritinib), including the dosage level, potential side effects and the ability of Zykadia to impact brain metastases.Bởi cancerGRACE - H. Jack West, MD
…
continue reading
1
Zykadia for ALK Positive Lung Cancer: New Drug, New Hope
7:22
7:22
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích
7:22
The doctors discuss the new FDA-approved drug for ALK positive lung cancer patients, Zykadia (ceritinib), including the dosage level, potential side effects and the ability of Zykadia to impact brain metastases.Bởi cancerGRACE - H. Jack West, MD
…
continue reading
1
No Clear Answer for Non-Clear Cell Kidney Cancer
5:41
5:41
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích
5:41
Drugs in early stage clinical trials seem to show benefit for non-clear cell kidney cancer, but more trials must take place and patients are desperately needed to enroll in them.Bởi cancerGRACE - H. Jack West, MD
…
continue reading
1
No Clear Answer for Non-Clear Cell Kidney Cancer
5:41
5:41
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích
5:41
Drugs in early stage clinical trials seem to show benefit for non-clear cell kidney cancer, but more trials must take place and patients are desperately needed to enroll in them.Bởi cancerGRACE - H. Jack West, MD
…
continue reading
1
What Went Wrong? The Failure of MetMab with Tarceva in Advanced Non-Small Cell Lung Cancer
3:52
3:52
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích
3:52
"Dead negative," is how Dr. Nasser Hanna describes results of a phase 3 study that examined how patients with high MET expression did on the drug MetMab (onartuzumab).Bởi cancerGRACE - H. Jack West, MD
…
continue reading
1
What Went Wrong? The Failure of MetMab with Tarceva in Advanced Non-Small Cell Lung Cancer
3:52
3:52
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích
3:52
"Dead negative," is how Dr. Nasser Hanna describes results of a phase 3 study that examined how patients with high MET expression did on the drug MetMab (onartuzumab).Bởi cancerGRACE - H. Jack West, MD
…
continue reading
Dr. Guru Sonpavde discusses what he does when he first begins treating a patient recently diagnosed with late stage kidney cancer.Bởi cancerGRACE - H. Jack West, MD
…
continue reading
Dr. Guru Sonpavde discusses what he does when he first begins treating a patient recently diagnosed with late stage kidney cancer.Bởi cancerGRACE - H. Jack West, MD
…
continue reading
1
MET-Amplified Lung Cancer: A New Target for XALKORI?
7:18
7:18
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích
7:18
Lung cancer patients with high MET amplification appear to do well on Xalcori (crizotinib), a drug that is approved for ALK positive patients.Bởi cancerGRACE - H. Jack West, MD
…
continue reading
1
MET-Amplified Lung Cancer: A New Target for XALKORI?
7:18
7:18
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích
7:18
Lung cancer patients with high MET amplification appear to do well on Xalcori (crizotinib), a drug that is approved for ALK positive patients.Bởi cancerGRACE - H. Jack West, MD
…
continue reading
1
The Hottest Thing in Late Stage Kidney Cancer
2:35
2:35
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích
2:35
Patients are responding very well to the next generation of immunotherapy drugs currently in clinical trials to treat kidney cancer.Bởi cancerGRACE - H. Jack West, MD
…
continue reading
1
The Hottest Thing in Late Stage Kidney Cancer
2:35
2:35
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích
2:35
Patients are responding very well to the next generation of immunotherapy drugs currently in clinical trials to treat kidney cancer.Bởi cancerGRACE - H. Jack West, MD
…
continue reading
1
CO1686 - 3rd Generation Drug for Acquired Resistance in EGFR Lung Cancer
4:10
4:10
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích
4:10
Lung cancer patients with the EGFR mutation who had progressed on other drugs did well on a new drug in clinical trial, though one particular side effect concerns some.Bởi cancerGRACE - H. Jack West, MD
…
continue reading
1
CO1686 - 3rd Generation Drug for Acquired Resistance in EGFR Lung Cancer
4:10
4:10
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích
4:10
Lung cancer patients with the EGFR mutation who had progressed on other drugs did well on a new drug in clinical trial, though one particular side effect concerns some.Bởi cancerGRACE - H. Jack West, MD
…
continue reading
1
The Promise of PD1 Inhibitors in Kidney Cancer
3:48
3:48
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích
3:48
Results from recent clinical trials looking into PD1 inhibitors of kidney cancer are giving patients and doctors reasons to be hopeful.Bởi cancerGRACE - H. Jack West, MD
…
continue reading
1
The Promise of PD1 Inhibitors in Kidney Cancer
3:48
3:48
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích
3:48
Results from recent clinical trials looking into PD1 inhibitors of kidney cancer are giving patients and doctors reasons to be hopeful.Bởi cancerGRACE - H. Jack West, MD
…
continue reading
1
FGFR and Its Role in Treating Squamous Cell Lung Cancer
2:21
2:21
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích
2:21
Fibroblast growth factor receptor (FGFR) mutations may play a role in the growth of squamous cell lung cancer. Dr. Jonathan Riess talks about what they are learning in this area.Bởi cancerGRACE - H. Jack West, MD
…
continue reading
1
FGFR and Its Role in Treating Squamous Cell Lung Cancer
2:21
2:21
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích
2:21
Fibroblast growth factor receptor (FGFR) mutations may play a role in the growth of squamous cell lung cancer. Dr. Jonathan Riess talks about what they are learning in this area.Bởi cancerGRACE - H. Jack West, MD
…
continue reading
1
AZD9291 for Acquired Resistance in EGFR Positive Lung Cancer
11:36
11:36
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích
11:36
EGFR positive lung cancer patients who had seen cancer progression responded well to a new drug in an early clinical trial.Bởi cancerGRACE - H. Jack West, MD
…
continue reading
1
AZD9291 for Acquired Resistance in EGFR Positive Lung Cancer
11:36
11:36
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích
11:36
EGFR positive lung cancer patients who had seen cancer progression responded well to a new drug in an early clinical trial.Bởi cancerGRACE - H. Jack West, MD
…
continue reading
1
What Are Heat Shock Protein (HSP) 90 Inhibitors and How May They Help Fight Lung Cancer?
2:17
2:17
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích
2:17
"HSP 90 inhibitors are a really cool class of drugs..." states Dr. Melissa Johnson of the Robert H. Lurie Comprehensive Cancer Center as she describes what researchers are learning about these drugs still in early development. February 2014.Bởi cancerGRACE - H. Jack West, MD
…
continue reading
1
What Are Heat Shock Protein (HSP) 90 Inhibitors and How May They Help Fight Lung Cancer?
2:17
2:17
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích
2:17
"HSP 90 inhibitors are a really cool class of drugs..." states Dr. Melissa Johnson of the Robert H. Lurie Comprehensive Cancer Center as she describes what researchers are learning about these drugs still in early development. February 2014.Bởi cancerGRACE - H. Jack West, MD
…
continue reading
Among kidney cancer patients, the sub-type "non-clear cell" is the least common. As a result, not much research has been conducted on it.Bởi cancerGRACE - H. Jack West, MD
…
continue reading
Among kidney cancer patients, the sub-type "non-clear cell" is the least common. As a result, not much research has been conducted on it.Bởi cancerGRACE - H. Jack West, MD
…
continue reading
1
Does Gilotrif Help EGFR Positive Lung Cancer Patients?
8:16
8:16
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích
8:16
An analysis of two large studies of EGFR lung cancer patients tried to determine if Gilotrif helped patients live longer.Bởi cancerGRACE - H. Jack West, MD
…
continue reading
1
The Promise of Immunotherapy in Lung Cancer
1:21
1:21
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích
1:21
Dr. Leena Gandhi of Dana-Farber Cancer Institute sees great potential in immune therapies for lung cancer. In this video, she expresses her hope and excitement for what the future may hold. February 2014.Bởi cancerGRACE - H. Jack West, MD
…
continue reading
1
The Promise of Immunotherapy in Lung Cancer
1:21
1:21
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích
1:21
Dr. Leena Gandhi of Dana-Farber Cancer Institute sees great potential in immune therapies for lung cancer. In this video, she expresses her hope and excitement for what the future may hold. February 2014.Bởi cancerGRACE - H. Jack West, MD
…
continue reading
1
Does Gilotrif Help EGFR Positive Lung Cancer Patients?
8:16
8:16
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích
8:16
An analysis of two large studies of EGFR lung cancer patients tried to determine if Gilotrif helped patients live longer.Bởi cancerGRACE - H. Jack West, MD
…
continue reading
1
Is Progression-Free Survival Meaningful?
3:25
3:25
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích
3:25
Progression-free survival is something that doctors measure to determine how well a patient responds to a particular treatment. But does it translate to increased overall survival?Bởi cancerGRACE - H. Jack West, MD
…
continue reading
1
Is Progression-Free Survival Meaningful?
3:25
3:25
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích
3:25
Progression-free survival is something that doctors measure to determine how well a patient responds to a particular treatment. But does it translate to increased overall survival?Bởi cancerGRACE - H. Jack West, MD
…
continue reading
1
DDR2 Mutations in Squamous Cell Lung Cancer
1:07
1:07
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích
1:07
A genetic mutation and a leukemia drug may provide new hope for patients with squamous cell lung cancer patients.Bởi cancerGRACE - H. Jack West, MD
…
continue reading
1
DDR2 Mutations in Squamous Cell Lung Cancer
1:07
1:07
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích
1:07
A genetic mutation and a leukemia drug may provide new hope for patients with squamous cell lung cancer patients.Bởi cancerGRACE - H. Jack West, MD
…
continue reading
1
Does Adding Avastin to Tarceva Help EGFR Positive Lung Cancer Patients?
9:26
9:26
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích
9:26
Drs. Nasser Hanna, Melissa Johnson and Jack West discuss results of a phase 2 trial presented at ASCO 2014 that studied if adding Avastin (bevicizumab) to Tarceva helped EGFR positive lung cancer patients increase progression-free survival. June 2014.Bởi cancerGRACE - H. Jack West, MD
…
continue reading
1
Does Adding Avastin to Tarceva Help EGFR Positive Lung Cancer Patients?
9:26
9:26
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích
9:26
Drs. Nasser Hanna, Melissa Johnson and Jack West discuss results of a phase 2 trial presented at ASCO 2014 that studied if adding Avastin (bevicizumab) to Tarceva helped EGFR positive lung cancer patients increase progression-free survival. June 2014.Bởi cancerGRACE - H. Jack West, MD
…
continue reading